Alzheimer's Disease: Drug Trials Targeting Amyloid Plaques and the Research Nurse's Role
Thu, Jun 08
|Zoom link will be emailed
The Research Nurse’s role in Alzheimer's Disease clinical trials is evolving with the use of amyloid beta-directed antibody drugs for AD research. Join us for a presentation on how CRNs can support their patients and identify risks during AD clinical trials.
Time & Location
Jun 08, 2023, 5:00 PM – 6:15 PM EDT
Zoom link will be emailed
Guests
About the event
We are on the verge of the first FDA full approval of an anti-amyloid therapy for patients with early AD. With this approval, it is anticipated that this treatment will be in high demand and will be widely prescribed. Experienced clinical research nurses who have worked on these trials are uniquely positioned to help translate into practice the nursing needs of managing this patient population and the risks associated with this class of drugs. This includes recommendations for patient and family education, identification of appropriate patients, monitoring for cognitive changes, ensuring that the prescribed protocol is followed, and advising on CMS required clinical registries. The CRN will also play a key role in assisting with designing future clinical research trials that take this new therapy into consideration along with applying the identified core principals of monitoring this patient population in a clinical trial.
Presented by:
Daniel Press, MD
Chief, Division…